HYFTNasdaqPharmaceutical PreparationsFiscal year ends April 30
MindWalk Holdings Corp.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 20-F on Jul 23, 2026
$1.32+0.01 (+0.76%)
Close on Oct 19, 2026
MindWalk Holdings Corp. revenue by segment
By business segment
By product or service
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Project Revenue | C$15.41M | C$10.40M | C$10.04M | C$18.68M | C$17.36M | C$15.91M | C$13.20M | 99.0% | +48.2% |
| Cryo Storage Revenue | C$152.00K | C$222.00K | C$223.00K | C$241.00K | C$356.00K | C$105.00K | C$124.00K | 1.0% | -31.5% |
| Product Sales Revenue | C$1.00K | C$7.00K | C$21.00K | C$1.75M | C$1.65M | C$1.90M | C$739.00K | 0.0% | -85.7% |
By region
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| United States | C$10.31M | C$8.66M | C$8.44M | C$9.37M | C$6.82M | C$7.93M | C$5.95M | 66.2% | +19.0% |
| Europe | C$2.80M | C$393.00K | C$929.00K | C$9.45M | C$9.43M | C$7.44M | C$6.12M | 18.0% | +611.2% |
| Other | C$1.08M | C$440.00K | C$44.00K | C$602.00K | C$1.01M | C$987.00K | C$1.28M | 7.0% | +146.4% |
| Australia | C$1.05M | C$896.00K | C$482.00K | C$630.00K | C$1.54M | C$468.00K | – | 6.7% | +17.2% |
| Canada | C$322.00K | C$234.00K | C$385.00K | C$618.00K | C$572.00K | C$1.09M | C$715.00K | 2.1% | +37.6% |
| Belgium | – | – | – | – | – | C$0 | – | – | – |
From the segment and revenue-disaggregation notes of MindWalk's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.